Join us at the conference to hear from and speak to our industry, incubator, and start-up representatives:
Evolv is a CE certified medical device manufacturer specialising in software and hardware development in the Digital Health field, specifically for rehabilitation. We are a spin-off of the company Virtualware, where, since 2011, an interdisciplinary team of engineers, designers and market specialists has worked on creating solutions for rehabilitation using the latest virtual reality, motion capture, and gaming technologies.
Centric Lab ® was established in 2016 with a mission to use the exponential potential of neuroscience to make healthier habitats for human life. In 2017 we began our partnership with University College London, through the acquisition of a prestigious Medical Research Council grant. The grant was in collaboration with Prof. Hugo Spiers, who is a leader in the neuroscience field of spatial cognition. The partnership with UCL provides us access to experiment facilities and world-leading neuroscientists. We are working specifically with the Ecological Brain cohort. This is the first of its kind, its aim is to bring neuroscience out of the lab to both develop the field of neuroscience and to provide industry with better insights behind human cognition and health. Our work was firmly established and inaugurated thanks to a report commissioned by Future Cities Catapult, titles ‘Neuroscience for Cities, which put forward techniques and guidelines to bring neuroscience into the industry. We like working with forward-thinking companies looking to create more human-centric, fit-for-purpose and resilient built environments that support human activity in an ever-increasing complex world.
Concentric Health’s mission is to transform how we make decisions – decisions shared by patient and clinician, and supported by data. The team passionately believe that by supporting patients to engage with, understand, and own decisions about their health, guided by personalised outcome predictions, we can transform healthcare decision-making. The company’s digital consent platform, used at a number of NHS trusts, is fixing the consent process – previously a paper-based, error-prone, disempowering process to one that is fit for the 21st century.
The University of Cambridge School of Clinical Medicine formulated a new initiative called the Experimental Medicine Training Initiative (EMI) in 2015. The EMI programme provides high quality training for motivated, bright and enthusiastic clinicians and clinical scientists in the design and execution of Experimental Medicine studies, equipping them with the knowledge and skills to lead Experimental Medicine studies in the future. This programme is supported by the University of Cambridge in partnership with the Cambridge University Hospitals, NIHR Cambridge Biomedical Research Centre and Industry Partners AstraZeneca/MedImmune and GSK, and it is designed to build capacity in Experimental Medicine (EM).
Part of the University of Cambridge, Cambridge Enterprise supports academics, researchers, staff and students in achieving knowledge transfer and research impact. We do this by helping innovators, experts and entrepreneurs use commercial avenues to develop their ideas and expertise for the benefit of society, the economy, themselves and the University. Liaising with organisations both locally and globally, we offer expert advice and support in commercialisation and social enterprise, including help with academic consultancy services; the protection, development and licensing of ideas; new company and social enterprise creation and seed funding.